APTOSE BIOSCIENCES INC (APTO)

CA03835T3091 - Common Stock

0.279  +0.11 (+63.92%)

After market: 0.225 -0.05 (-19.35%)

Buy % Consensus

83

ChartMill assigns a Buy % Consensus number of 83% to APTO. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.08. This target is 1362.37% above the current price.
APTO was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about APTO.
In the previous month the buy percentage consensus was at a similar level.
APTO was analyzed by 8 analysts. More opinions would make the average more meaningful.

Price Target & Forecast

Price Low Median Mean High 0.282.024.084.086.30 - 624.01% 1,362.37% 1,362.37% 2,158.06%
Up and Down Grades
Date Firm Action Rating
2024-12-10 HC Wainwright & Co. Reiterate Buy -> Buy
2024-12-03 HC Wainwright & Co. Reiterate Buy -> Buy
2024-11-20 HC Wainwright & Co. Maintains Buy -> Buy
2024-06-14 HC Wainwright & Co. Reiterate Buy -> Buy
2024-05-16 Canaccord Genuity Maintains Buy -> Buy
2024-04-03 Piper Sandler Maintains Overweight -> Overweight
2024-03-27 HC Wainwright & Co. Maintains Buy -> Buy
2024-02-01 Piper Sandler Maintains Overweight -> Overweight
2023-11-10 RBC Capital Maintains Outperform -> Outperform
2023-09-07 Cantor Fitzgerald Reiterate Overweight -> Overweight
2023-08-11 Oppenheimer Maintains Outperform -> Outperform
2023-08-11 RBC Capital Maintains Outperform -> Outperform
2023-08-11 Piper Sandler Maintains Overweight -> Overweight
2023-08-11 HC Wainwright & Co. Maintains Buy -> Buy
2023-06-12 Cantor Fitzgerald Maintains Overweight
2023-06-12 Oppenheimer Maintains Outperform -> Outperform
2023-06-12 HC Wainwright & Co. Maintains Buy -> Buy
2023-06-07 RBC Capital Maintains Outperform -> Outperform
2023-06-07 Piper Sandler Maintains Overweight -> Overweight
2023-05-09 Oppenheimer Reiterate Outperform
2023-05-09 RBC Capital Reiterate Outperform
2023-05-09 HC Wainwright & Co. Reiterate Buy
2023-03-27 Canaccord Genuity Maintains Buy
2023-03-24 RBC Capital Reiterate Outperform
2022-11-02 RBC Capital Maintains Outperform
2022-05-10 RBC Capital Maintains Outperform
2021-12-21 HC Wainwright & Co. Maintains Buy
2021-11-12 HC Wainwright & Co. Maintains Buy